Laboratory Centrifuges Market by Product (Equipment and Consumables), Application (Cardiology, Endocrinology, Oncology, Therapeutic Drug Development & Monitoring, Infectious Disease Testing, Drugs Of Abuse Testing and others) End user (Hospitals And Clinics, Diagnostic Laboratories, Research Labs & Institutes, Biopharmaceutical & Biotechnology Companies and Others): Global Market Size Estimates and Forecast (2022-2030)

Code: BMIRE00026828 | Pages: 100 | Industry: Biotechnology | Date: Oct 2022 | Type: Global

The market crossed US$ 1.70 billion mark in 2022 and is expected to hit US$ 2.32 billion by 2030, recording a CAGR of 3.2% during the forecast period.

Cosumables segment held the largest share by product segment.

Based on the product, the laboratory centrifuge market  is segmented equipment and consumables. The consumables segment held the largest share in 2022 and it is also anticipated to grow at highest CAGR during the forecast period. The growth of the segment can be attributed repeated purchase of accessories such as tubes, bottles, and buckets during the forecast period.

Within the report, the market is segmented into product, application, end user, geography. By product, the market is bifurcated into equipment and consumables. By application the market is segmented into cardiology, endocrinology, oncology, therapeutic drug development & monitoring, infectious disease testing, drugs of abuse testing and others. In terms of end user the market is segmented  into hospitals and clinics, diagnostic laboratories, research labs & institutes, biopharmaceutical & biotechnology companies and others. Geographically, the market is sub segmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.

Get more information on this report :

Rising Number of Product Launches is likely to drive the market growth

Technological advancements and innovations in centrifuges is likely to propel the growth of the market during the forecast period. For instance, in April 2021, Eppendorf, a life science company launched a new Centrifuge 5910 Ri that will enhance the efficiency in the laboratory.  Similarly, in February 2020, Biosan introduced LMC-56 Laboratory Centrifuge, a bench-top, low speed multifunctional centrifuge for routine laboratory tasks.

Emerging Markets in Developing Countries is likely to create growth opportunities for the market.

The growing healthcare industry in the developing countries in Asia Pacific is creating better opportunities for the major market players to expand their business. Moreover, huge patient population in emerging countries is generating demand for advanced diagnostic systems. For instance, according to the global burden of disease data, India has 18% of the world’s population, but it has 32% of global burden of respiratory diseases. Similarly, according to the new Tulane University study published in 2018, 8.6% of the Chinese population suffers from the chronic lung disease. Additionally, implementation of intense market penetration strategies in the region are anticipated to strengthen the market in the region.

Recent strategic developments in Laboratory centrifuge market  

The laboratory centrifuge market has undergone several significant developments, and a few of these have been mentioned below:

  • In 2021, KUBOTA Corporation introduced the Benchtop Centrifuge S500T and Floor-Standing Refrigerated Centrifuge S500FR.
  • In 2020, Eppendorf AG introduced a refrigerated 24-place centrifuge 5425 R, which offers protection to temperature-sensitive samples

The laboratory centrifuge market is driven by several players by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. BD, Danaher Corporation, Agilent Technologies, Inc., Koki Holdings Co., Ltd., QIAGEN, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Sigma Laborzentrifugen GmbH, Eppendorf AG and Andreas Hettich GmbH & Co.KG are among the prominent players operating in the market.

Target audience for the report:

  • Manufacturing Companies
  • Government & Research Organizations
  • Organizations, Forums, Alliances & Associations
  • State & National Authorities
  • Dealers & Suppliers And Vendors

 

 

Scope of the report:

In this report, the market has been segmented on the basis of:

 

  • Product
    • Equipments
    • Consumables
  • Technique
    • Cardiology
    • Endocrinology
    • Oncology
    • Therapeutic Drug Development & Monitoring
    • Infectious Disease Testing
    • Drugs Of Abuse Testing
    • Others
  • End User
    • Hospitals And Clinics
    • Diagnostic Laboratories
    • Research Labs & Institutes
    • Biopharmaceutical & Biotechnology Companies
    • Others
  • Region
    • North America
    • Europe
    • Asia Pacific (APAC)
    • South & Central America
    • Middle East & Africa
  • Companies profiled
    • BD
    • Danaher Corporation
    • Agilent Technologies, Inc.
    • Koki Holdings Co., Ltd.
    • QIAGEN
    • Bio-Rad Laboratories, Inc.
    • Thermo Fisher Scientific Inc.
    • Sigma Laborzentrifugen GmbH
    • Eppendorf AG
    • Andreas Hettich GmbH & Co.KG

The List of Companies
- BD
- Danaher Corporation
- Agilent Technologies, Inc.
- Koki Holdings Co., Ltd.
- QIAGEN
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- Sigma Laborzentrifugen GmbH
- Eppendorf AG
- Andreas Hettich GmbH & Co.KG

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$2000
Site License
$3000
Enterprise License
$4000